Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Open access

Abstract

BACKGROUND: Neurological disorders are now the leading source of disability globally, and ageing is increasing the burden of neurodegenerative disorders, including Parkinson's disease. We aimed to determine the global burden of Parkinson's disease between 1990 and 2016 to identify trends and to enable appropriate public health, medical, and scientific responses. METHODS: Through a systematic analysis of epidemiological studies, we estimated global, regional, and country-specific prevalence and years of life lived with disability for Parkinson's disease from 1990 to 2016. We estimated the proportion of mild, moderate, and severe Parkinson's disease on the basis of studies that used the Hoehn and Yahr scale and assigned disability weights to each level. We jointly modelled prevalence and excess mortality risk in a natural history model to derive estimates of deaths due to Parkinson's disease. Death counts were multiplied by values from the Global Burden of Disease study's standard life expectancy to compute years of life lost. Disability-adjusted life-years (DALYs) were computed as the sum of years lived with disability and years of life lost. We also analysed results based on the Socio-demographic Index, a compound measure of income per capita, education, and fertility. FINDINGS: In 2016, 6·1 million (95% uncertainty interval [UI] 5·0-7·3) individuals had Parkinson's disease globally, compared with 2·5 million (2·0-3·0) in 1990. This increase was not solely due to increasing numbers of older people, because age-standardised prevalence rates increased by 21·7% (95% UI 18·1-25·3) over the same period (compared with an increase of 74·3%, 95% UI 69·2-79·6, for crude prevalence rates). Parkinson's disease caused 3·2 million (95% UI 2·6-4·0) DALYs and 211 296 deaths (95% UI 167 771-265 160) in 2016. The male-to-female ratios of age-standardised prevalence rates were similar in 2016 (1·40, 95% UI 1·36-1·43) and 1990 (1·37, 1·34-1·40). From 1990 to 2016, age-standardised prevalence, DALY rates, and death rates increased for all global burden of disease regions except for southern Latin America, eastern Europe, and Oceania. In addition, age-standardised DALY rates generally increased across the Socio-demographic Index. INTERPRETATION: Over the past generation, the global burden of Parkinson's disease has more than doubled as a result of increasing numbers of older people, with potential contributions from longer disease duration and environmental factors. Demographic and potentially other factors are poised to increase the future burden of Parkinson's disease substantially. FUNDING: Bill & Melinda Gates Foundation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(18)30295-3

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Age-standardised prevalence of Parkinson's disease per 100 000 population by location for both sexes, 2016 ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. Isl=Islands. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
Figure 1 Age-standardised prevalence of Parkinson's disease per 100 000 population by location for both sexes, 2016 ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. Isl=Islands. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.CC BY · PubMed Central
Figure 2 Global prevalence of Parkinson's disease by age and sex, 2016 Prevalence is expressed as the percentage of the population that is affected by the disease. Shading indicates 95% uncertainty intervals.
Figure 2 Global prevalence of Parkinson's disease by age and sex, 2016 Prevalence is expressed as the percentage of the population that is affected by the disease. Shading indicates 95% uncertainty intervals.CC BY · PubMed Central
Figure 3 Global YLD and YLL rates per 100 000 population due to Parkinson's disease by age, 2016 Shading indicates 95% uncertainty intervals. YLDs=years lived with disability. YLLs=years of life lost.
Figure 3 Global YLD and YLL rates per 100 000 population due to Parkinson's disease by age, 2016 Shading indicates 95% uncertainty intervals. YLDs=years lived with disability. YLLs=years of life lost.CC BY · PubMed Central
Figure 4 Age-standardised DALY rates for Parkinson's disease by 21 Global Burden of Disease regions by Socio-demographic Index, 1990–2016 Expected values based on Socio-demographic Index and disease rates in all locations are shown as the black line. The black line represents expected values of age-standardised DALY rates for each value of Socio-demographic Index and is based on a Gaussian process regression of results for all Global Burden of Disease locations over the entire 1990–2016 estimation period. DALY=disability-adjusted life-year.
Figure 4 Age-standardised DALY rates for Parkinson's disease by 21 Global Burden of Disease regions by Socio-demographic Index, 1990–2016 Expected values based on Socio-demographic Index and disease rates in all locations are shown as the black line. The black line represents expected values of age-standardised DALY rates for each value of Socio-demographic Index and is based on a Gaussian process regression of results for all Global Burden of Disease locations over the entire 1990–2016 estimation period. DALY=disability-adjusted life-year.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 2,816

Metadata

Authors
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., Collado-Mateo, D., Dahodwala, N., Do, H. P., Edessa, D., Endres, M., Fereshtehnejad, S.-M., Foreman, K. J., Gankpe, F. G., Gupta, R., Hamidi, S., Hankey, G. J., Hay, S. I., Hegazy, M. I., Hibstu, D. T., Kasaeian, A., Khader, Y., Khalil, I., Khang, Y.-H., Kim, Y. J., Kokubo, Y., Logroscino, G., Massano, J., Mohamed Ibrahim, N., Mohammed, M. A., Mohammadi, A., Moradi-Lakeh, M., Naghavi, M., Nguyen, B. T., Nirayo, Y. L., Ogbo, F. A., Owolabi, M. O., Pereira, D. M., Postma, M. J., Qorbani, M., Rahman, M. A., Roba, K. T., Safari, H., Safiri, S., Satpathy, M., Sawhney, M., Shafieesabet, A., Shiferaw, M. S., Smith, M., Szoeke, C. E. I., Tabarés-Seisdedos, R., Truong, N. T., Ukwaja, K. N., Venketasubramanian, N., Villafaina, S., weldegwergs, K. G., Westerman, R., Wijeratne, T., Winkler, A. S., Xuan, B. T., Yonemoto, N., Feigin, V. L., Vos, T., & Murray, C. J. L.
Affiliations
  • University of Rochester (US)
  • Inserm (FR)
  • Xiamen University Malaysia (MY)
  • Seoul National University (KR)
  • Baqiyatallah University of Medical Sciences (IR)
  • Duy Tan University (VN)
  • Jigjiga University (ET)
  • Cairo University (EG)
  • Universidade do Porto (PT)
  • Universidad de Extremadura (ES)
  • Iran University of Medical Sciences (IR)
  • University Medical Center Groningen (NL)
Corresponding author
  • Dorsey, E. Ray
  • Elbaz, Alexis
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2018-11
Volume
17
Issue
11
Pages
939-953
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2901519529
Cited by
2,816
References
49
Citations by year
2026: 335 · 2025: 418 · 2024: 424 · 2023: 406 · 2022: 435 · 2021: 422 · 2020: 279 · 2019: 87 · 2018: 6
FWCI
135.05
Type
journal article
Language
en
Update notices
erratum (2021-12-01)
Open access
Licence
Locations
  • The Lancet Neurology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc-nd)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
  • Research Bank (Australian Catholic University) (submittedVersion, cc-by)
  • Tuwhera (Auckland University of Technology) (submittedVersion, other-oa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
  • Figshare (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
  • Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, cc-by)
  • Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-nd)
  • La Trobe University (cc-by)
Funders
  • Alzheimer's Association
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords
Parkinson's disease, disease burden, prevalence, disability-adjusted life years, years of life lost, excess mortality, age-standardized prevalence, disease severity, Hoehn and Yahr stage, disability weights, natural history model, socio-demographic index, neurodegenerative diseases, disability, sex differences
MeSH terms
Global Burden of Disease, Female, Persons with Disabilities, Humans, Life Expectancy, Longitudinal Studies, Male, Parkinson Disease, Global Health, Prevalence, Risk Assessment, International Classification of Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. https://app.cochat.ai/papers/10.1016/s1474-4422(18)30295-3
The paper
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., Collado-Mateo, D., Dahodwala, N., Do, H. P., Edessa, D., Endres, M., Fereshtehnejad, S.-M., Foreman, K. J., Gankpe, F. G., Gupta, R., . . . Murray, C. J. L. (2018). Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(18)30295-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.